Source:http://linkedlifedata.com/resource/pubmed/id/10529627
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-12-20
|
pubmed:abstractText |
Lipoprotein glomerulopathy (LPG) is a newly recognized renal disease characterized by abnormal lipoprotein deposition in the glomeruli, dysbetalipoproteinemia, and a high level of plasma apolipoprotein (apo) E. We identified a novel apo E mutation in a 56-year-old Japanese male with LPG. Although the plasma cholesterol and triglyceride levels were normal, the levels of intermediate-density lipoprotein cholesterol and apo E were elevated to 13 mg/dl (0.336 mmol/l; 4.2+/-2.9 mg/dl, mean +/- SD, in 12 normolipidemic controls) and 9.2 mg/dl, respectively. Biochemical analysis revealed an unusual apo E phenotype (E1/3). Apo E genotyping using DNA digested by a restriction enzyme (HhaI) identified a 66-bp fragment which was not seen with any of the common alleles. Sequence analysis of the amplified genomic DNA fragments showed a 9-bp deletion in exon 4 of the apo E gene resulting in a 3-amino acid deletion (residues 141-143). This novel mutation involves the region of the apo E molecule known to be critically involved in binding to its receptor, and this may well transform the apo E molecule, an inefficient ligand, to its receptor(s). How this mutations causes glomerular damage remains to be determined.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0028-2766
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
214-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10529627-Apolipoproteins E,
pubmed-meshheading:10529627-Base Sequence,
pubmed-meshheading:10529627-Biopsy,
pubmed-meshheading:10529627-Capillaries,
pubmed-meshheading:10529627-Cholesterol, HDL,
pubmed-meshheading:10529627-Cholesterol, LDL,
pubmed-meshheading:10529627-Cholesterol, VLDL,
pubmed-meshheading:10529627-DNA Mutational Analysis,
pubmed-meshheading:10529627-Humans,
pubmed-meshheading:10529627-Kidney Diseases,
pubmed-meshheading:10529627-Kidney Glomerulus,
pubmed-meshheading:10529627-Male,
pubmed-meshheading:10529627-Middle Aged,
pubmed-meshheading:10529627-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:10529627-Sequence Deletion,
pubmed-meshheading:10529627-Thrombosis,
pubmed-meshheading:10529627-Tokyo
|
pubmed:year |
1999
|
pubmed:articleTitle |
Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy.
|
pubmed:affiliation |
Department of Medicine and Pathology, School of Medicine Keio University, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports
|